INTEGRA LIFESCIENCES HOLDINGS CORPORATION

Highlights Integra LifeSciences Holdings Corporation

Equities

IART

US4579852082

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-16 pm EDT			5-day change	1st Jan Change
27.49 ^USD	+3.85%		+8.66%	-36.88%

May. 07	Truist Cuts Price Target on Integra LifeSciences Holdings to $25 From $37, Keeps Hold Rating	MT
May. 07	Wells Fargo Downgrades Integra LifeSciences Holdings to Equalweight From Overweight, Cuts Price Target to $25 From $45	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Integra LifeSciences Shares Drop to Record Low on Unexpected Loss, Boston Facility Audit Findings	May. 06	DJ
Integra LifeSciences Q1 Adjusted Earnings, Revenue Fall; Updates 2024 Outlook	May. 06	MT
Integra LifeSciences Holdings Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 06	CI
Earnings Flash (IART) INTEGRA LIFESCIENCES HOLDINGS CORPORATION Reports Q1 Revenue $368.9M, vs. Street Est of $362M	May. 06	MT
Earnings Flash (IART) INTEGRA LIFESCIENCES HOLDINGS CORPORATION Posts Q1 EPS $0.55, vs. Street Est of $0.55	May. 06	MT
Integra LifeSciences Holdings Corporation Provides Revenue Guidance for the Second Quarter of 2024	May. 06	CI
Integra LifeSciences Completes Acquisition of Acclarent	Apr. 01	MT
Integra LifeSciences Holdings Corporation acquired 100% stake in Acclarent, Inc. from Ethicon US, LLC for $280 million.	Mar. 31	CI
Integra Lifesciences Launches Micromatrix Flex to Provide Convenient Access to Hard-To-Reach Areas in Complex Cases	Mar. 11	CI
Tranche Update on Integra LifeSciences Holdings Corporation's Equity Buyback Plan announced on July 27, 2023.	Feb. 28	CI
Integra LifeSciences Shares Drop Following Q4 Results	Feb. 28	MT
Integra LifeSciences Seeks Acquisitions	Feb. 28	CI
Integra LifeSciences' Q4 Adjusted Earnings, Revenue Decline	Feb. 28	MT
Integra Lifesciences Holdings Corporation Provides Earnings Guidance for the First Quarter and for the Full Year 2024	Feb. 28	CI
Integra LifeSciences Holdings Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 28	CI
Earnings Flash (IART) INTEGRA LIFESCIENCES HOLDINGS CORPORATION Posts Q4 Revenue $397M, vs. Street Est of $399.2M	Feb. 28	MT
Earnings Flash (IART) INTEGRA LIFESCIENCES HOLDINGS CORPORATION Reports Q4 EPS $0.89, vs. Street Est of $0.90	Feb. 28	MT
Integra LifeSciences Holdings Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 28	CI
Integra LifeSciences Agrees to Buy Acclarent for $275 million at Deal Closing	Dec. 13	MT
Integra LifeSciences to Buy Acclarent From Johnson & Johnson	Dec. 13	DJ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Integra LifeSciences Holdings Corporation

Equities

IART

US4579852082

Highlights

Filters